Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged vs Regular Anticoagulation in COPD with PTE
NCT03185845Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jun 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of warfarin in pulmonary thromboembolism (PE) (2 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Venous thromboembolism recurrence at 3 years. Status: unknown.
02
Drugs
warfarin
03
Conditions
pulmonary thromboembolism (PE)
Beyond the preview
Go deeper on NCT03185845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03185845.